VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 110 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $183,509 | -91.8% | 42,479 | -87.5% | 0.00% | – |
Q2 2023 | $2,233,515 | -79.8% | 338,925 | -79.2% | 0.00% | -100.0% |
Q1 2023 | $11,075,441 | +424.7% | 1,631,140 | +471.1% | 0.00% | – |
Q4 2022 | $2,110,667 | -38.6% | 285,611 | -17.9% | 0.00% | – |
Q3 2022 | $3,438,000 | -34.1% | 347,925 | -27.3% | 0.00% | -100.0% |
Q2 2022 | $5,219,000 | +48.4% | 478,709 | +54.0% | 0.00% | – |
Q1 2022 | $3,516,000 | -42.3% | 310,830 | -19.9% | 0.00% | -100.0% |
Q4 2021 | $6,089,000 | +15.4% | 388,050 | +26.1% | 0.00% | 0.0% |
Q3 2021 | $5,277,000 | -11.8% | 307,776 | +10.7% | 0.00% | 0.0% |
Q2 2021 | $5,981,000 | +57.7% | 278,063 | +10.1% | 0.00% | – |
Q1 2021 | $3,792,000 | +31.8% | 252,512 | +15.3% | 0.00% | – |
Q4 2020 | $2,878,000 | +2.5% | 218,963 | -24.7% | 0.00% | – |
Q3 2020 | $2,809,000 | +0.9% | 290,768 | +19.5% | 0.00% | – |
Q2 2020 | $2,785,000 | +14.4% | 243,401 | +3.6% | 0.00% | – |
Q1 2020 | $2,435,000 | -22.8% | 234,959 | +22.3% | 0.00% | – |
Q4 2019 | $3,154,000 | +5.1% | 192,180 | -15.0% | 0.00% | – |
Q3 2019 | $3,001,000 | -54.6% | 226,009 | -51.9% | 0.00% | -100.0% |
Q2 2019 | $6,617,000 | -42.1% | 469,598 | -24.3% | 0.00% | -50.0% |
Q1 2019 | $11,420,000 | +42.8% | 620,650 | +102.8% | 0.00% | +100.0% |
Q4 2018 | $7,995,000 | +6.3% | 306,012 | -6.6% | 0.00% | 0.0% |
Q3 2018 | $7,520,000 | +107.8% | 327,630 | +72.5% | 0.00% | 0.0% |
Q2 2018 | $3,619,000 | +16.8% | 189,936 | +3.3% | 0.00% | 0.0% |
Q1 2018 | $3,098,000 | +20.5% | 183,896 | +8.7% | 0.00% | – |
Q4 2017 | $2,572,000 | -24.9% | 169,155 | -11.6% | 0.00% | -100.0% |
Q3 2017 | $3,425,000 | +77.7% | 191,284 | +61.8% | 0.00% | – |
Q2 2017 | $1,927,000 | +97.2% | 118,250 | +69.4% | 0.00% | – |
Q1 2017 | $977,000 | -20.9% | 69,815 | -9.8% | 0.00% | – |
Q4 2016 | $1,235,000 | +36.8% | 77,376 | +42.5% | 0.00% | – |
Q3 2016 | $903,000 | +51.3% | 54,305 | +1.7% | 0.00% | – |
Q2 2016 | $597,000 | +277.8% | 53,406 | +182.7% | 0.00% | – |
Q1 2016 | $158,000 | -46.1% | 18,892 | -39.9% | 0.00% | – |
Q4 2015 | $293,000 | -17.2% | 31,460 | +0.1% | 0.00% | – |
Q3 2015 | $354,000 | -52.9% | 31,416 | -47.0% | 0.00% | – |
Q2 2015 | $752,000 | -51.5% | 59,268 | -64.4% | 0.00% | – |
Q1 2015 | $1,550,000 | +850.9% | 166,507 | +1367.9% | 0.00% | – |
Q4 2014 | $163,000 | -11.4% | 11,343 | -36.4% | 0.00% | – |
Q3 2014 | $184,000 | -31.6% | 17,821 | +7.1% | 0.00% | – |
Q2 2014 | $269,000 | -71.7% | 16,640 | -71.6% | 0.00% | – |
Q1 2014 | $951,000 | -39.3% | 58,546 | -53.6% | 0.00% | -100.0% |
Q4 2013 | $1,566,000 | -45.0% | 126,148 | -51.5% | 0.00% | 0.0% |
Q3 2013 | $2,846,000 | +32.4% | 259,922 | -2.3% | 0.00% | 0.0% |
Q2 2013 | $2,149,000 | – | 265,991 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |